No abstract available
MeSH terms
-
Aged
-
Anaplastic Lymphoma Kinase
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cyclophosphamide / administration & dosage
-
Doxorubicin / administration & dosage
-
Dual-Specificity Phosphatases / genetics*
-
Female
-
Gene Rearrangement
-
Humans
-
Lymphoma, Large-Cell, Anaplastic / drug therapy
-
Lymphoma, Large-Cell, Anaplastic / genetics*
-
Mitogen-Activated Protein Kinase Phosphatases / genetics*
-
Prednisone / administration & dosage
-
Transcription Factors / genetics*
-
Tumor Suppressor Proteins / genetics*
-
Vincristine / administration & dosage
Substances
-
TP63 protein, human
-
Transcription Factors
-
Tumor Suppressor Proteins
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
ALK protein, human
-
Anaplastic Lymphoma Kinase
-
Mitogen-Activated Protein Kinase Phosphatases
-
DUSP22 protein, human
-
Dual-Specificity Phosphatases
-
Prednisone